Difficulty: Medium
Average Score: 69%
Practice
A 9mo-old infant develops a left adrenal mass; histological examination with genetic characteristics confirms neuroblastoma. Which of the following carries a better outcome?
Correct answer
B
Rationale
The correct answer is option B) hyperdiploidy. In pediatric neuroblastoma, hyperdiploidy is associated with a better prognosis. Hyperdiploidy refers to an extra set of chromosomes, which is a favorable genetic characteristic in neuroblastoma and is linked to a less aggressive form of the disease. This leads to a lower risk of disease progression and better treatment response.
Option A) amplification of the MYCN proto-oncogene is associated with a poorer prognosis in neuroblastoma. This genetic alteration indicates a more aggressive form of the disease with a higher risk of progression.
Option C) loss of heterozygosity of 17q chromosome and option D) loss of 1p chromosome are also associated with unfavorable outcomes in neuroblastoma. These genetic changes are linked to higher-risk disease features and poorer response to treatment.
In an educational context, understanding the genetic characteristics of pediatric neuroblastoma is crucial for nurses and healthcare professionals caring for pediatric oncology patients. Recognizing the implications of different genetic alterations can guide treatment decisions and help predict patient outcomes, ultimately improving the quality of care provided to children with neuroblastoma.
Option A) amplification of the MYCN proto-oncogene is associated with a poorer prognosis in neuroblastoma. This genetic alteration indicates a more aggressive form of the disease with a higher risk of progression.
Option C) loss of heterozygosity of 17q chromosome and option D) loss of 1p chromosome are also associated with unfavorable outcomes in neuroblastoma. These genetic changes are linked to higher-risk disease features and poorer response to treatment.
In an educational context, understanding the genetic characteristics of pediatric neuroblastoma is crucial for nurses and healthcare professionals caring for pediatric oncology patients. Recognizing the implications of different genetic alterations can guide treatment decisions and help predict patient outcomes, ultimately improving the quality of care provided to children with neuroblastoma.